Sensient Technologies Corporation
NYSE:SXTChemicals - Specialty
-$0.08 today
- Market cap
- $5.00B
- Beta
- 0.79
- P/E (TTM)
- 32.5
- EPS (TTM)
- $3.41
- Dividend yield
- 1.48%
Volume 0.20M
Average 0.42M
SXT EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Sensient Technologies CorporationNYSE: SXT
EBITDA · Q2 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q2 FY2026 EBITDA of $92.59M rose 26.9% year over year, ahead of the +13.9% change in trailing-twelve-month EBITDA. Sequentially, it rose 12.5% from the prior quarter. Over 3 fiscal years it compounded at +2.5% a year.
Context
- EBITDA amounted to 16.6% of revenue in FY2025, up 0.5 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 3 analysts of $332.95M (+24.1%) for the fiscal year ending Dec 2026, a step up from the +6.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $92.59M+12.5% QoQ
- Last fiscal yearDec 2025
- $268.23M+6.5% YoY
- LTMJun 2026
- $301.51M+13.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +26.9% | +17.8% | -9.1 pp |
| 1 year | +6.5% | +24.1% | +17.7 pp |
| 3-year CAGR | +2.5% | +19.8% | +17.4 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 268.23M USD
- Year-over-year change
- +6.5%
- 4-year CAGR
- +4.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 268.23M | +6.5% |
| FY2024 | 2024-12-31 | 251.91M | +18.4% |
| FY2023 | 2023-12-31 | 212.84M | -14.6% |
| FY2022 | 2022-12-31 | 249.22M | +12.2% |
| FY2021 | 2021-12-31 | 222.08M | — |
EBITDA vs competitors
How SXT compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +13.9% is the 5th highest of 11, against a peer median of +10.7%.
- EBITDA amounts to 17.7% of revenue for SXT, versus a peer median of 16.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2026 | ZAR 69.09B ZAR | +94.0% | +0.6% | 25.9% | |
| LTM Jun 2026 | $690M USD | -14.9% | +13.9% | 19.0% | |
| LTM Aug 2026 | $540.79M USD | +11.0% | +2.4% | 15.2% | |
| LTM Sep 2026 | $506.9M USD | +19.1% | +16.5% | 14.8% | |
| LTM Jun 2026 | $493.68M USD | +14.9% | +16.8% | 14.9% | |
| LTM Jun 2026 | $385M USD | +49.2% | -47.4% | 4.0% | |
| LTM Jun 2026 | $301.51M USD | +13.9% | +2.5% | 17.7% | |
| LTM Sep 2026 | $275.03M USD | +10.4% | +9.2% | 24.8% | |
| LTM Sep 2026 | $183.41M USD | +8.8% | +15.0% | 16.1% | |
| LTM Aug 2026 | $119.43M USD | +5.4% | +6.5% | 17.4% | |
| LTM Jun 2026 | -$300.15M USD | -303.2% | — | 39.6% | |
| Peer median (excluding SXT) | — | +10.7% | +9.2% | 16.7% | |
Competitors are the stored peer set for SXT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.38B | 1.44B | 1.46B | 1.56B | 1.61B |
| Cost of Revenue | 925.52M | 947.93M | 996.15M | 1.05B | 1.07B |
| Gross Profit | 454.75M | 489.11M | 460.3M | 507.09M | 539.3M |
| Gross Margin | 32.9% | 34.0% | 31.6% | 32.6% | 33.5% |
| Research & Development | 34.3M | 42.2M | 48.1M | 49.1M | 0 |
| Selling, General & Admin | 250.27M | 250.16M | 257.17M | 266.41M | 332.17M |
| Operating Expenses | 284.57M | 292.36M | 305.27M | 315.51M | 332.17M |
| Depreciation & Amortization | 52.05M | 52.47M | 57.82M | 60.33M | 61.1M |
| EBITDA | 222.08M | 249.22M | 212.84M | 251.91M | 268.23M |
| EBITDA Margin | 16.1% | 17.3% | 14.6% | 16.2% | 16.6% |
| Operating Income | 170.18M | 196.75M | 155.02M | 191.58M | 207.13M |
| Operating Margin | 12.3% | 13.7% | 10.6% | 12.3% | 12.8% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 12.54M | 14.55M | 25.17M | 28.78M | 29.58M |
| Other Income / Expenses | (12.69M) | (14.55M) | (25.17M) | (28.78M) | (29.58M) |
| Income Before Tax | 157.48M | 182.2M | 129.85M | 162.8M | 177.55M |
| Pre-Tax Margin | 11.4% | 12.7% | 8.9% | 10.5% | 11.0% |
| Income Tax Expense | 38.74M | 41.32M | 36.46M | 38.13M | 43.06M |
| Net Income | 118.75M | 140.89M | 93.39M | 124.67M | 134.49M |
| Net Margin | 8.6% | 9.8% | 6.4% | 8.0% | 8.3% |
| EPS (Basic) | 2.82 | 3.36 | 2.22 | 2.96 | 3.18 |
| EPS (Diluted) | 2.81 | 3.34 | 2.21 | 2.94 | 3.16 |
| Weighted Avg Shares | 42.08M | 41.89M | 42.03M | 42.15M | 42.24M |
| Weighted Avg Shares (Diluted) | 42.26M | 42.21M | 42.24M | 42.4M | 42.6M |
Sensient Technologies Corporation
NYSE:SXT
Intrinsic Alpha fair value
Locked
Current Price
$117.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.